Flushing and gastrointestinal tolerability events in relapsing remitting multiple sclerosis (RRMS) patients treated with oral BG-12 dimethyl fumarate) in the phase 3 DEFINE and CONFIRM trials

被引：0
|
作者：
Selmaj, K. [1 ]
Gold, R. [2 ]
Fox, R. J. [3 ]
Havrdova, E. [4 ]
Giovannoni, G. [5 ]
Pace, A.
Novas, M.
Meltzer, L.
Hotermans, C.
Viglietta, V.
Phillips, J. T. [6 ]
机构：
[1] Med Univ Lodz, Lodz, Poland
[2] Ruhr Univ Bochum, St Josef Hosp, Bochum, Germany
[3] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA
[4] Charles Univ Prague, Prague, Czech Republic
[5] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England
[6] Baylor Inst Immunol Res, Dallas, TX USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2013年 / 19卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：221 / 221
页数：1
相关论文
共 50 条
  • [1] Gastrointestinal Tolerability Events in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients Treated with Oral BG-12 (Dimethyl Fumarate) in DEFINE and CONFIRM
    Meltzer, Leslie
    Selmaj, Krzysztof
    Gold, Ralf
    Fox, Robert
    Havrdova, Eva
    Giovannoni, Gavin
    Pace, Amy
    Novas, Mark
    Hotermans, Christophe
    Dawson, Katherine
    Phillips, J. Theodore
    NEUROLOGY, 2013, 80
  • [2] Gastrointestinal Tolerability Events in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients Treated with Oral Bg-12 (Dimethyl Fumarate) in Define and Confirm
    Bar-Or, A.
    Selmaj, K.
    Gold, R.
    Fox, R. J.
    Havrdova, E.
    Kurukulasuriya, N. C.
    Pace, A.
    Novas, M.
    Meltzer, L.
    Hotermans, C.
    Dawson, K. T.
    Phillips, J. T.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (12) : 1840 - 1841
  • [3] Oral BG-12 (dimethyl fumarate) for relapsing-remitting multiple sclerosis: a review of DEFINE and CONFIRM
    Havrdova, Eva
    Hutchinson, Michael
    Kurukulasuriya, Nuwan C.
    Raghupathi, Kartik
    Sweetser, Marianne T.
    Dawson, Katherine T.
    Gold, Ralf
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (15) : 2145 - 2156
  • [4] Effect of BG-12 (dimethyl fumarate) in newly diagnosed relapsing remitting multiple sclerosis (RRMS) patients from the DEFINE and CONFIRM studies
    Gold, R.
    Giovannoni, G.
    Phillips, J. T.
    Fox, R. J.
    Zhang, A.
    Meltzer, L.
    Kurukulasuriya, N. C.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 453 - 454
  • [5] Efficacy of Oral BG-12 (Dimethyl Fumarate) in Patients Newly Diagnosed with Relapsing-Remitting Multiple Sclerosis (RRMS): Integrated Analysis of DEFINE and CONFIRM
    Gold, R.
    Giovannoni, G.
    Phillips, J. T.
    Fox, R. J.
    Rana, J.
    Zhang, A.
    Meltzer, L.
    Kurukulasuriya, N. C.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 931 - 932
  • [6] Clinical Efficacy of BG-12 (Dimethyl Fumarate) in Relapsing-Remitting Multiple Sclerosis (RRMS): An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies
    Fox, Robert
    Miller, David
    Phillips, J. Theodore
    Arnold, Douglas
    Selmaj, Krzysztof
    Yang, Minhua
    Zhang, Ray
    Dawson, Katherine
    Viglietta, Vissia
    Sheikh, Sarah
    Gold, Ralf
    NEUROLOGY, 2013, 80
  • [7] Clinical Efficacy and Safety of Oral Bg-12 (Dimethyl Fumarate) In Relapsing-Remitting Multiple Sclerosis (RRMS): An Integrated Analysis of the Phase 3 Define and Confirm Studies
    Bar-Or, A.
    Gold, R.
    Fox, R. J.
    Havrdova, E.
    Selmaj, K.
    Kurukulasuriya, N. C.
    Yang, M.
    Raghupathi, K.
    Novas, M.
    Sweetser, M. T.
    Viglietta, V.
    Dawson, K. T.
    Phillips, J. T.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (12) : 1828 - 1828
  • [8] Effects of BG-12 (Dimethyl Fumarate) on Quality of Life in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS): An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies
    Kita, Mariko
    Fox, Robert
    Gold, Ralf
    Giovannoni, Gavin
    Phillips, J. Theodore
    Sarda, Sujata
    Kong, Jessica
    Viglietta, Vissia
    Sheikh, Sarah
    Dawson, Katherine
    Kappos, Ludwig
    NEUROLOGY, 2013, 80
  • [9] CLINICAL AND NEURORADIOLOGICAL EFFECT OF BG-12 (DIMETHYL FUMARATE) IN SUBGROUPS OF PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS): AN INTEGRATED ANALYSIS OF THE PHASE 3 DEFINE AND CONFIRM STUDIES
    Bar-Or, A.
    Fox, R. J.
    Gold, R.
    Miller, D. H.
    Arnold, D. L.
    O'Gorman, J.
    Yang, M.
    Sheikh, S., I
    Viglietta, V.
    Dawson, K. T.
    Hutchinson, M.
    VALUE IN HEALTH, 2013, 16 (03) : A102 - A102
  • [10] Clinical and Neuroradiologic Efficacy of BG-12 (Dimethyl Fumarate) in US Patients with Relapsing-Remitting Multiple Sclerosis (RRMS): An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies
    Kita, Mariko
    Fox, Robert
    Phillips, J. Theodore
    Arnold, Douglas
    Bar-Or, Amit
    Yang, Minhua
    Zhang, Ray
    Dawson, Katherine
    Viglietta, Vissia
    Sheikh, Sarah
    Gold, Ralf
    NEUROLOGY, 2013, 80
12345